Compliance in Online Discussion Technologies

April 6, 2017Article

Pharmaceutical companies are looking for convenient, cost-effective ways to engage physicians, patients, payers, and other external stakeholders throughout the drug development lifecycle. Online discussion technologies have been praised by teams and external stakeholders alike for being efficient and effective.  When first considering online discussion technologies, however, pharma companies often have initial compliance concerns.

We were able to maintain pre, during, and post compliance control – which meant that my team and I could confidently focus on gathering critical insights.

Medical Affairs Team Leader